106 results
Page 4 of 6
8-K
yu1owmvuy iqxc
29 Jun 17
Entry into a Material Definitive Agreement
8:00pm
DEF 14A
h6vl25adnxeqn5gyd
29 Apr 15
Definitive proxy
8:00pm
10-Q
u0q 80z216azt
12 Aug 09
Quarterly report
8:00pm
424B3
dg5g0p1zd6l7dn 9dtze
30 Jan 20
Prospectus supplement
5:09pm
S-3
EX-10.1
vth8by69vi6fm6
20 Apr 04
Shelf registration
8:00pm
S-1/A
q5w8nzxl5va3 7yvun3
27 Jan 20
IPO registration (amended)
4:47pm
8-K
EX-1.1
s2wu jysforr9kcf1
26 Feb 15
Transgenomic Announces Commencement of Public Offering of Common Stock
7:00pm
10-K
EX-10.34
12d2bu 75y
13 Apr 16
Annual report
8:00pm
DEF 14A
7zg6wh
29 Apr 20
Definitive proxy
4:32pm
10-Q
vekkcws 4sg
13 May 09
Quarterly report
8:00pm
424B3
mrnhnun6t7
27 Sep 06
Prospectus supplement
8:00pm
PREM14A
9k0llm5x
2 Feb 17
Preliminary proxy related to merger
7:00pm
S-3
mjn kikcf
17 Jul 06
Shelf registration
8:00pm
8-K
EX-4.1
9johe8nhdmpk el
3 Jan 11
Transgenomic Announces Closing of the Acquisition of Clinical Data’s Diagnostic Business and the Closing of a $6 Million Financing
7:00pm
DEFM14A
kf1o imd7a13kqmmh
11 May 17
Proxy related to merger
8:00pm
PRER14A
l141rp
7 May 17
Preliminary revised proxy
8:00pm
PRER14A
ht6eplyl
23 Apr 17
Preliminary revised proxy
8:00pm
8-K
EX-10.2
xuac9zr
5 Mar 14
Transgenomic Announces $7 Million Convertible Preferred Stock Financing
7:00pm
424B3
mdjy36bw01x3p
13 Dec 05
Prospectus supplement
7:00pm
8-K
EX-10.01
yxv6lp13a7g0huki
5 Jan 12
Transgenomic Announces $3 Million Convertible Note Financing
7:00pm